SHEA ARNOLD: Open Payments
NPI 1417192774 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 65 payments from 10 companies in 2025. Trend: 2023 $881 · 2024 $1,232 · 2025 $1,018
Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $334 |
| Ipsen Biopharmaceuticals, Inc | 10 | $222 |
| Janssen Biotech, Inc. | 8 | $137 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| GENZYME CORPORATION | 3 | $64 |
| Lilly USA, LLC | 3 | $52 |
| Laborie Medical Technologies Corp. | 1 | $46 |
| Gilead Sciences, Inc. | 2 | $31 |
| QOL Medical, LLC | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
Products named: IQIRVO, RINVOQ, TREMFYA, LINZESS, ZENPEP, DUPIXENT, OMVOH, CREON.
Industry payments across AR — which companies pay providers there.
